中集車輛(01839.HK)更改部份所得款項用途
中集車輛(01839.HK)公布,就有關申請A股上市一事,因最終實際可資本化的承銷佣金、酌情花紅及其他上市費用較預估金額減少,故擬將增加金額全數分配於「營運資金及一般企業用途」項下。
同時考慮到2020年上半年中美貿易爭端不確定性及全球新冠肺炎疫情對集團在北美業務的開展產生了一定程度的影響,董事會決定減少原分配於美國骨架車項目投資金額1.8億元,並重新分配於中國地區新增項目;另外,因應公司對智能物流裝備與服務產業未來發展的認同,公司計劃以有限合夥人身份與獨立第三方共同設立產業基金,計劃自全球發售的所得款項淨額向基金投資約8,410萬元,並會於未來5年使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.